Clinical trials recruiting for Metabolic Dysfunction-associated Steatotic Liver Disease
13
Recruiting trials
35
US states with sites
34
Countries
15%
Accept healthy volunteers
Phase breakdown
Phase 1 2Phase 2 1Phase 3 1Not applicable 10
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| ALN-CIDEB | 1 |
| Menopausal hormone therapy | 1 |
| Pectin | 1 |
| Probiotics | 1 |
| Retatrutide | 1 |
| Taiwan green propolis capsule | 1 |
| Tirzepatide | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 2 |
| Massachusetts | 2 |
| South Carolina | 2 |
| West Virginia | 2 |
| Alabama | 1 |
| Arkansas | 1 |
| California | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| Florida | 1 |
| Georgia | 1 |
| Illinois | 1 |
Top cities
Chandler, Arizona 2Tucson, Arizona 2Akron, Ohio 1Albuquerque, New Mexico 1Aurora, Colorado 1Austin, Texas 1Baltimore, Maryland 1Bastrop, Louisiana 1Beavercreek, Ohio 1Bellaire, Texas 1
Self-screener
Recruiting trials
- A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
- A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
- Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population
- Advanced Fibrosis Detection for MASLD in Primary Care
- Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme
- COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study
- Development of Microbial Therapeutics for Metabolic-associated Fatty Liver Disease: From Mechanistic Investigations to Clinical Trials
- Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
- Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)
- Taiwan Green Propolis for Blood Lipids and Body Fat in Patients With MASLD
- The Establishment of Hong Kong Diabetes Steatotic Liver Disease Register
- The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Related conditions
Trials recruiting for Metabolic Dysfunction-associated Steatotic Liver Disease often also study these conditions. Each links to its own recruiting-trial list.
NASH 218Type 2 diabetes 891Obesity 1512Non-alcoholic Fatty Liver Disease NAFLD 10Metabolic Dysfunction-Associated Steatohepatitis 5MASLD 15Liver Fibrosis 16Type 2 Diabetes (T2DM) 16Psoriasis 233Plaque Psoriasis 25
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metabolic Dysfunction-associated Steatotic Liver Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.